×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Predictive Genetic Testing and Consumer Wellness Genomics Market

ID: MRFR/LS/9360-HCR
120 Pages
Rahul Gotadki
October 2025

Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, ... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Predictive Genetic Testing and Consumer Wellness Genomics Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Predictive Genetic Testing and Consumer Wellness Genomics Market Summary

As per MRFR analysis, the Predictive Genetic Testing and Consumer Wellness Genomics Market was estimated at 4650.03 USD Million in 2024. The market is projected to grow from 5097.17 USD Million in 2025 to 11421.09 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.47 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Predictive Genetic Testing and Consumer Wellness Genomics Market is experiencing robust growth driven by technological advancements and increasing consumer engagement.

  • The market is witnessing a rise in personalized health solutions, particularly in North America, which remains the largest market.
  • Technological integration in testing is enhancing the accuracy and accessibility of genetic tests, especially in the Asia-Pacific region, the fastest-growing market.
  • The evolving regulatory landscape is shaping the operational frameworks for genetic testing, fostering innovation and compliance.
  • Key market drivers include increasing consumer awareness and advancements in genetic technologies, which are propelling demand for disease risk assessment and pharmacogenomics solutions.

Market Size & Forecast

2024 Market Size 4650.03 (USD Million)
2035 Market Size 11421.09 (USD Million)
CAGR (2025 - 2035) 8.47%

Major Players

23andMe (US), Ancestry (US), MyHeritage (IL), Invitae (US), Color Genomics (US), Gene by Gene (US), Fulgent Genetics (US), Genetic Technologies (AU), Pathway Genomics (US)

Predictive Genetic Testing and Consumer Wellness Genomics Market Trends

The Predictive Genetic Testing and Consumer Wellness Genomics Market is currently experiencing a notable evolution, driven by advancements in technology and increasing consumer awareness regarding health and wellness. This market encompasses a range of services that allow individuals to gain insights into their genetic predispositions, enabling proactive health management. As consumers become more health-conscious, the demand for personalized health solutions appears to be on the rise. Companies are increasingly focusing on developing user-friendly platforms that provide accessible genetic information, which may lead to more informed lifestyle choices and preventive health measures. Moreover, the integration of artificial intelligence and machine learning into genetic testing processes seems to enhance the accuracy and efficiency of results. This technological advancement not only streamlines the testing process but also improves the interpretation of genetic data, making it more comprehensible for consumers. As the market continues to expand, regulatory frameworks are likely to evolve, ensuring that ethical considerations are addressed while maintaining consumer trust. The Predictive Genetic Testing and Consumer Wellness Genomics Market is poised for further growth, as it aligns with the broader trend of personalized medicine and wellness-oriented consumer behavior.

Rise of Personalized Health Solutions

The demand for tailored health solutions is increasing as consumers seek to understand their genetic makeup. This trend indicates a shift towards personalized wellness strategies, where individuals can make informed decisions based on their genetic predispositions.

Technological Integration in Testing

The incorporation of advanced technologies, such as artificial intelligence, is transforming the testing landscape. This integration enhances the accuracy of results and facilitates better data interpretation, making genetic information more accessible to consumers.

Evolving Regulatory Landscape

As the market expands, regulatory frameworks are adapting to address ethical concerns and ensure consumer protection. This evolution suggests a growing emphasis on maintaining trust and transparency within the Predictive Genetic Testing and Consumer Wellness Genomics Market.

Market Segment Insights

By Application: Disease Risk Assessment (Largest) vs. Pharmacogenomics (Fastest-Growing)

The Predictive Genetic Testing and Consumer Wellness Genomics Market exhibits a diverse application landscape, with Disease Risk Assessment currently commanding the largest market share. This area focuses on evaluating an individual’s genetic predisposition to various diseases, which significantly aids in preventive healthcare strategies. Carrier Testing and Nutrigenomics follow closely, contributing meaningful shares as they cater to consumer demands for personalized health insights and nutrition-related genetic information. Growth trends in this segment are primarily driven by increasing health awareness and advancements in genetic technology. Pharmacogenomics, which analyzes how genes affect a person's response to drugs, has emerged as the fastest-growing segment. The rising interest in personalized medicine and tailored healthcare solutions supports its expansion, alongside an increase in investment in genetic research and technology-driven healthcare services.

Disease Risk Assessment (Dominant) vs. Nutrigenomics (Emerging)

Disease Risk Assessment is a dominant segment within the Predictive Genetic Testing and Consumer Wellness Genomics Market due to its critical role in preventive healthcare. It empowers consumers to understand their genetic vulnerabilities and adopt proactive health measures, making it a preferred choice among healthcare providers. On the other hand, Nutrigenomics is an emerging segment that focuses on how genetics influence individual responses to nutrients and dietary choices. This area is gaining traction as health-conscious consumers seek tailored dietary recommendations to optimize their well-being. The growing body of research linking nutrition and genetics positions Nutrigenomics as a significant player for future market growth, appealing particularly to those looking to enhance their wellness through dietary personalization.

By End Use: Healthcare Providers (Largest) vs. Direct-to-Consumer (Fastest-Growing)

In the Predictive Genetic Testing and Consumer Wellness Genomics Market, the Healthcare Providers segment exhibits the largest market share, serving as a critical touchpoint for genetic testing services. They leverage genetic testing to personalize treatment plans and enhance patient outcomes. Meanwhile, the Direct-to-Consumer segment is rapidly gaining traction as consumers increasingly seek control over their health data and personalized wellness insights, thus driving its growth in the genomics landscape.

Healthcare Providers (Dominant) vs. Direct-to-Consumer (Emerging)

Healthcare Providers remain dominant in the Predictive Genetic Testing and Consumer Wellness Genomics Market, integrating genetic testing into clinical practice to provide tailored healthcare solutions. This segment benefits from established trust with patients and the ability to deliver comprehensive care based on genetic insights. In contrast, the Direct-to-Consumer segment is emerging as a significant player, thriving on consumer demand for accessible and understandable genetic information. DTC companies focus on user-friendly interfaces, allowing individuals to engage with their health data without the intermediary role of healthcare professionals. Both segments highlight the evolving landscape of genetics in healthcare, catering to distinct consumer needs.

By Technology: Next Generation Sequencing (Largest) vs. Whole Genome Sequencing (Fastest-Growing)

In the Predictive Genetic Testing and Consumer Wellness Genomics Market, the technology segment reveals a varied distribution among its segments. Next Generation Sequencing (NGS) stands out as the largest technology, accounting for a significant portion of the market share due to its ability to quickly sequence large portions of DNA. Other methods like Polymerase Chain Reaction (PCR) and Microarray Technology also play crucial roles, but their shares are comparatively smaller. Sanger Sequencing, once the gold standard, now occupies a niche position as newer technologies gain prominence. The growth trends in this segment are primarily driven by the increasing demand for personalized medicine and consumer wellness applications. Next Generation Sequencing continues to dominate as platforms become more accessible, while Whole Genome Sequencing is rapidly emerging as a popular choice for comprehensive genetic analysis, fueled by advancements in technology and decreasing costs. As consumers increasingly seek proactive health management, these technologies are expected to see robust growth in the coming years.

Technology: Next Generation Sequencing (Dominant) vs. Whole Genome Sequencing (Emerging)

Next Generation Sequencing (NGS) is recognized as the dominant technology in the Predictive Genetic Testing and Consumer Wellness Genomics Market due to its high throughput capabilities and cost-effectiveness. It allows for extensive analysis of genetic variations, essential for personalized treatments and wellness initiatives. Meanwhile, Whole Genome Sequencing, classified as an emerging technology, is gaining traction as it provides a complete picture of an individual's genetic makeup. It is valuable for detecting rare genetic disorders and tailoring wellness programs to individual needs, thereby appealing to health-conscious consumers. As advancements in sequencing technologies continue, both NGS and Whole Genome Sequencing will shape the future landscape of genomics in health and wellness.

By Test Type: Predictive Testing (Largest) vs. Prenatal Testing (Fastest-Growing)

The Predictive Genetic Testing and Consumer Wellness Genomics Market exhibits diverse segment values that cater to varying consumer needs. Among these, Predictive Testing holds the largest market share, reflecting its established position in genetic testing, providing essential insights for assessing health risks. In contrast, Prenatal Testing is carving out a significant niche, capturing the attention of expectant parents seeking to understand genetic conditions in their unborn children, thus marking it as a notable player in the market.

Testing Methods: Predictive Testing (Dominant) vs. Prenatal Testing (Emerging)

Predictive Testing serves as a dominant force within the Predictive Genetic Testing and Consumer Wellness Genomics Market. It specializes in forecasting potential genetic disorders, leading to informed health decisions. This segment benefits from increased awareness and acceptance of genetic insights among consumers. On the other hand, Prenatal Testing is rapidly emerging as a vital segment by providing critical information to expectant parents. With technological advancements enhancing accuracy and accessibility, this segment is experiencing significant growth, driven by societal trends that prioritize maternal and fetal health. Additionally, the proactive approach of parents-to-be towards genetic testing positions Prenatal Testing as a key driver in the evolution of consumer wellness genomics.

By Consumer Segment: Health Conscious Individuals (Largest) vs. Families with Genetic Disorders (Fastest-Growing)

In the Predictive Genetic Testing and Consumer Wellness Genomics Market, the landscape is shaped by a diverse array of consumer segments. The largest segment, Health Conscious Individuals, demonstrates a prominent appetite for personal wellness and is driven by an increasing awareness of preventive healthcare practices. This demographic comprises a significant portion of overall consumer interest, as they leverage genetic insights to make informed lifestyle choices and uphold optimal health. Conversely, Families with Genetic Disorders are emerging as the fastest-growing segment within this market. The rising prevalence of genetic disorders has heightened the demand for predictive testing among families seeking proactive health management solutions. This segment's growth is further propelled by advancements in genetic testing technologies and increased accessibility to results, enabling informed decisions regarding familial health and long-term planning.

Health Conscious Individuals (Dominant) vs. Families with Genetic Disorders (Emerging)

Health Conscious Individuals represent a dominant force in the Predictive Genetic Testing and Consumer Wellness Genomics Market, driven by a growing trend toward personal health optimization. This segment actively seeks genetic insights to enhance their lifestyle choices, making them early adopters of genetic testing technologies. Their engagement is characterized by a willingness to invest in health and wellness, influencing market dynamics and pushing for innovation in genetic testing services. On the other hand, Families with Genetic Disorders are classified as an emerging segment. Their need for predictive genetic testing stems from the desire for risk assessment and early intervention. As healthcare systems evolve, this segment's growth reflects a critical demand for tailored solutions that ensure informed healthcare decisions and enhance family planning strategies.

Get more detailed insights about Predictive Genetic Testing and Consumer Wellness Genomics Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the Predictive Genetic Testing and Consumer Wellness Genomics Market, holding a significant market share of $2325.01M in 2025. The growth is driven by increasing consumer awareness, advancements in technology, and supportive regulatory frameworks. The demand for personalized health insights and preventive healthcare solutions is on the rise, further fueled by the integration of genetic testing in routine healthcare practices. The United States is the primary contributor to this market, with key players like 23andMe, Ancestry, and Invitae leading the charge. The competitive landscape is characterized by continuous innovation and strategic partnerships among companies. The presence of established firms and a robust healthcare infrastructure enhances market growth, making North America a hub for genetic testing advancements.

Europe : Emerging Market with Potential

Europe is witnessing a growing interest in Predictive Genetic Testing and Consumer Wellness Genomics, with a market size of $1150.0M in 2025. Factors such as increasing healthcare expenditure, rising awareness of genetic disorders, and supportive government initiatives are driving this growth. Regulatory bodies are also promoting the integration of genetic testing into healthcare systems, enhancing accessibility and affordability for consumers. Leading countries in this region include Germany, the UK, and France, where companies like MyHeritage and Color Genomics are making significant strides. The competitive landscape is evolving, with new entrants and innovations emerging. The European market is characterized by a mix of established players and startups, fostering a dynamic environment for growth and collaboration.

Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region is rapidly emerging in the Predictive Genetic Testing and Consumer Wellness Genomics Market, with a market size of $850.0M in 2025. The growth is driven by increasing disposable incomes, rising health awareness, and advancements in healthcare technology. Governments are also implementing policies to promote genetic testing, which is expected to further boost market demand in the coming years. Countries like Australia, Japan, and China are leading the charge, with companies such as Genetic Technologies and Pathway Genomics expanding their presence. The competitive landscape is becoming more vibrant, with both local and international players vying for market share. The region's diverse population and varying healthcare needs present unique opportunities for tailored genetic testing solutions.

Middle East and Africa : Emerging Frontier for Testing

The Middle East and Africa region is gradually emerging in the Predictive Genetic Testing and Consumer Wellness Genomics Market, with a market size of $325.02M in 2025. The growth is driven by increasing healthcare investments, rising awareness of genetic health, and the need for personalized medicine. Regulatory frameworks are evolving to support the integration of genetic testing into healthcare systems, enhancing consumer access to these services. Countries like South Africa and the UAE are at the forefront of this market, with a growing number of local and international players entering the space. The competitive landscape is characterized by collaborations and partnerships aimed at expanding service offerings. As the region continues to develop, the demand for genetic testing is expected to rise significantly, presenting new opportunities for growth.

Key Players and Competitive Insights

The Predictive Genetic Testing and Consumer Wellness Genomics Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing consumer awareness regarding health and wellness. Major players such as 23andMe (US), Ancestry (US), and Invitae (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. 23andMe (US) focuses on innovation through its direct-to-consumer model, emphasizing user-friendly genetic testing kits that provide actionable health insights. Ancestry (US), on the other hand, leverages its extensive genealogical database to offer unique ancestry-related genetic testing, thereby creating a niche market. Invitae (US) is strategically positioned towards clinical applications, aiming to integrate genetic testing into routine healthcare, which reflects a broader trend towards personalized medicine. Collectively, these strategies contribute to a competitive environment that is increasingly centered on consumer engagement and technological integration.

In terms of business tactics, companies are increasingly localizing their operations to enhance supply chain efficiency and reduce costs. The market structure appears moderately fragmented, with a mix of established players and emerging startups. This fragmentation allows for diverse offerings, yet the influence of key players remains substantial, as they set industry standards and drive innovation. The competitive dynamics suggest that companies must continuously adapt to maintain relevance in a rapidly evolving market.

In November 2025, 23andMe (US) announced a partnership with a leading health insurance provider to offer subsidized genetic testing for preventive health measures. This strategic move is likely to enhance accessibility for consumers, potentially increasing the adoption rate of genetic testing services. By aligning with health insurance, 23andMe (US) not only broadens its market reach but also positions itself as a key player in preventive healthcare, which is becoming increasingly prioritized in the industry.

In October 2025, Ancestry (US) launched a new feature that combines genetic data with historical records, allowing users to explore their ancestry in a more interactive manner. This innovation is significant as it enhances user engagement and adds value to the consumer experience, thereby differentiating Ancestry (US) from its competitors. The integration of genetic insights with historical context may attract a broader audience, particularly those interested in genealogy.

In September 2025, Invitae (US) expanded its genetic testing portfolio by acquiring a smaller biotech firm specializing in rare genetic disorders. This acquisition is indicative of Invitae's commitment to broadening its clinical applications and enhancing its service offerings. By integrating specialized knowledge and technology, Invitae (US) is likely to strengthen its position in the clinical genetic testing market, which is expected to grow as healthcare systems increasingly adopt personalized medicine approaches.

As of December 2025, current competitive trends in the Predictive Genetic Testing and Consumer Wellness Genomics Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing technological capabilities and market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize research and development, alongside strategic partnerships, will likely emerge as leaders in this burgeoning market.

Key Companies in the Predictive Genetic Testing and Consumer Wellness Genomics Market market include

Industry Developments

    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

Future Outlook

Predictive Genetic Testing and Consumer Wellness Genomics Market Future Outlook

The Predictive Genetic Testing and Consumer Wellness Genomics Market is projected to grow at an 8.47% CAGR from 2024 to 2035, driven by technological advancements and increasing consumer awareness.

New opportunities lie in:

  • Development of personalized wellness plans based on genetic insights.
  • Expansion of direct-to-consumer genetic testing services.
  • Integration of AI-driven analytics for enhanced predictive accuracy.

By 2035, the market is expected to be robust, driven by innovation and consumer demand.

Market Segmentation

Predictive Genetic Testing and Consumer Wellness Genomics Market End Use Outlook

  • Healthcare Providers
  • Research Institutions
  • Direct-to-Consumer
  • Pharmaceutical Companies
  • Insurance Companies

Predictive Genetic Testing and Consumer Wellness Genomics Market Test Type Outlook

  • Predictive Testing
  • Diagnostic Testing
  • Carrier Testing
  • Prenatal Testing
  • Newborn Screening

Predictive Genetic Testing and Consumer Wellness Genomics Market Technology Outlook

  • Next Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray Technology
  • Sanger Sequencing
  • Whole Genome Sequencing

Predictive Genetic Testing and Consumer Wellness Genomics Market Application Outlook

  • Disease Risk Assessment
  • Carrier Testing
  • Pharmacogenomics
  • Nutrigenomics
  • Ancestry Testing

Predictive Genetic Testing and Consumer Wellness Genomics Market Consumer Segment Outlook

  • Health Conscious Individuals
  • Families with Genetic Disorders
  • Athletes and Fitness Enthusiasts
  • Individuals Seeking Ancestry Information
  • Patients with Chronic Conditions

Report Scope

MARKET SIZE 20244650.03(USD Million)
MARKET SIZE 20255097.17(USD Million)
MARKET SIZE 203511421.09(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)8.47% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled23andMe (US), Ancestry (US), MyHeritage (IL), Invitae (US), Color Genomics (US), Gene by Gene (US), Fulgent Genetics (US), Genetic Technologies (AU), Pathway Genomics (US)
Segments CoveredApplication, End Use, Technology, Test Type, Consumer Segment
Key Market OpportunitiesIntegration of artificial intelligence in predictive genetic testing enhances personalized consumer wellness solutions.
Key Market DynamicsRising consumer demand for personalized health insights drives innovation in predictive genetic testing and wellness genomics.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓